HOME >> MEDICINE >> NEWS
New study: Pine bark significantly reduces endometriosis

There's promising hope for women who suffer from endometriosis, one of the most common causes of infertility and pelvic pain. A new study to be published in an upcoming edition of the Journal of Reproductive Medicine reveals that Pycnogenol (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree, significantly reduces symptoms of endometriosis by 33 percent.

Pycnogenol which holds a patent for reducing PMS/menstrual pain and discomfort, was chosen for this study because other endometriosis treatments can have unwanted side effects. "The cause of endometriosis is unknown and treatment to fully cure endometriosis has yet to be developed," said Dr. Takafumi Kohama, a lead researcher of the study. "Common hormone treatments such as gonadotropin-releasing hormone agents (Gn-RHa) may likely restrict women from becoming pregnant during treatment. Danazol, another hormone treatment, produces side effects such as ovarian deficiency, osteoporosis and obesity. Our results convey Pycnogenol as an extremely effective natural treatment without dangerous side effects," he said.

The study, held at Kanazawa University School of Medicine, Ishokawa, Japan, sampled 58 women ages 21?8 who underwent operations for endometriosis within six months prior to the study. After confirming regular menstruation and ovulation for three months before treatment, patients were examined before and at 4,12, 24 and 48 weeks after treatment began to check for symptom control (pain, urinary and bowel symptom, breakthrough bleeding). Pain was evaluated by patients self-assessment and an investigator interviewed and performed a gynecologic examination.

Patients were randomized to two groups: Pycnogenol and Gn-RHa. Patients who supplemented with Pycnogenol took 30 mg capsules orally twice daily for 48 weeks immediately after morning and evening meals. Patients who received the Gn-RHa therapy received injected leuprorelin acetate dep
'"/>

Contact: Melanie Nimrodi
mnimrodi@mww.com
312-546-3508
MWW Group
7-Mar-2007


Page: 1 2 3

Related medicine news :

1. HealthGrades study: Bariatric surgery patients have fewer complications at high-volume hospitals
2. Case study: cross-cultural bioethics training program helps fight African brain drain
3. New study: Pycnogenol reduces heart failure
4. FSU study: Can prunes reverse bone loss after menopause?
5. New study: Preterm birth causes one-third of all infant deaths
6. FSU study: Abortion notification, consent laws reduce risky teen sex
7. National study: Patients poorly prepared for end-of-life decisions
8. UCLA/VA study: Many patients not receiving follow-up tests after positive screening for colon cancer
9. U-M study: Program to boost elderly flu vaccination could save lives
10. Loyola study: Telemetry captures stroke patients cardiac problems
11. Mayo Clinic study: People with heart failure at significant increase for death from stroke

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New study Pine bark significantly reduces endometriosis

(Date:5/20/2013)... (PRWEB) May 20, 2013 This summer, ... the world will make the pilgrimage to San Diego, ... annual Digital Health Summer Summit produced by ... a unique forum to showcase the latest digital health ... practices, and network with some of industry’s most brilliant ...
(Date:5/20/2013)... May 20, 2013 For more than ... waged a battle against drug and alcohol abuse around ... released its first guide to help Italian speakers reverse ... by the European Monitoring Centre for Drugs and Drug ... have used cannabis in the last year. As a ...
(Date:5/20/2013)... HealthDay Reporter , , MONDAY, May 20 (HealthDay News) -- ... out in the late 1990s is more effective than ... contends. Teenagers who received four shots with the ... were 2 years old were significantly less likely to ... in California, compared to children who received all of ...
(Date:5/20/2013)... What is it about toothpaste that transforms the sweet ... the solution to that mysterious sensory phenomenon in ... the American Chemical Society,s award-winning Bytesize Science ... from the world,s largest scientific society, explains that the ... lauryl sulfate, or SLS for short. When you brush ...
(Date:5/20/2013)... MAYWOOD, Il. - Nearly three out of ... disorders during their pregnancies, a Loyola University Medical Center ... only minimal impacts on pregnant women,s quality of life, ... Scott Graziano, MD and Payton Johnson was presented during ... Clinical Meeting in New Orleans. , One hundred and ...
Breaking Medicine News(10 mins):Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 2Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 3Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 4Health News:First Narconon Cannabis Abuse Prevention Guide Takes Aim at Drug Abuse Statistics for Italian Youth 2Health News:Study: Older Whooping Cough Vaccine More Effective 2Health News:Study: Older Whooping Cough Vaccine More Effective 3Health News:72 percent of pregnant women experience constipation and other bowel problems 2
(Date:5/20/2013)... 2013  AbbVie (NYSE: ABBV ) ... clinical study called SONAR (Study Of Diabetic Nephropathy ... investigational compound atrasentan - when added to standard of ... with stage 2 to 4 chronic kidney disease ... large, multinational, double-blind, placebo-controlled clinical study that is ...
(Date:5/19/2013)... ORLANDO, Fla. , May 19, 2013 /PRNewswire/ ... power and low temperature radiofrequency (RF) energy is ... and eliminates or reduces the need for medication ... long-term assessment presented today at the Digestive Disease ... Orlando, Florida . ...
(Date:5/17/2013)... SHANGHAI , May 17, 2013 Medical ... drug nor a biological product. In light of their ... trail evaluations are much more complicated than drug trails ... only evaluates MD safety instead of evaluating both safety ... the US FDA (which is the same as the ...
Breaking Medicine Technology:AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 3Statistical Challenges in Medical Device Trail Evaluation 2
Cached News: